Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 07 Jan 2008 for Omrix Biopharmaceuticals, Inc., €137k.
Insider track record
Disclosed buys
0
Disclosed sells
4
Signal history
No signal scores available.
Michael Burshtine: trading record in brief
Michael Burshtine discloses dealings in Omrix Biopharmaceuticals, Inc. to SEC (Form 4). Between 16 January 2007 and 4 January 2008, the trades on record add up to 9 filings.
The open-market record consists of 4 sales worth €2.6M, with no purchase. The rest of the record consists of 1 share grant and 4 option exercises. Since January 2008: no purchases and 4 sales on the market.
Most recently, on 7 January 2008, the filings show an open-market sale worth €753k in Omrix Biopharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Michael Burshtine
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
32,665 shares@ US$6.19Common StockSEC:0001209191-08-002277:0
32,665 shares@ US$34.00Common StockSEC:0001209191-08-002277:1
70,091 shares@ US$6.19Common StockSEC:0001209191-08-001649:0
70,091 shares@ US$34.45Common StockSEC:0001209191-08-001649:1
6,335 shares@ US$6.19Common StockSEC:0001209191-08-001649:2
6,335 shares@ US$34.01Common StockSEC:0001209191-08-001649:3
4,546 shares@ US$13.75Common StockSEC:0001209191-08-001649:4
4,546 shares@ US$34.02Common StockSEC:0001209191-08-001649:5
5,000 shares0Common Stock, par value $0.01 per shareSEC:0001209191-07-004117:0
9 of 9 declarations
